Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
116.9
USD
|
+1.65%
|
|
+4.22%
|
-19.10%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,745
|
15,705
|
27,346
|
25,406
|
16,955
|
13,736
|
-
|
-
|
Enterprise Value (EV)
1 |
10,182
|
18,530
|
29,301
|
27,124
|
20,232
|
17,685
|
17,356
|
18,528
|
P/E ratio
|
14.5
x
|
41.9
x
|
221
x
|
9.49
x
|
10.8
x
|
18.2
x
|
9.33
x
|
6.72
x
|
Yield
|
2.01%
|
1.04%
|
0.67%
|
0.73%
|
-
|
1.41%
|
1.42%
|
1.47%
|
Capitalization / Revenue
|
2.16
x
|
5.02
x
|
8.22
x
|
3.47
x
|
1.76
x
|
2.28
x
|
1.86
x
|
1.57
x
|
EV / Revenue
|
2.84
x
|
5.92
x
|
8.8
x
|
3.71
x
|
2.1
x
|
2.93
x
|
2.35
x
|
2.12
x
|
EV / EBITDA
|
9.82
x
|
22.6
x
|
33.6
x
|
7.8
x
|
6
x
|
14.1
x
|
9.12
x
|
8.28
x
|
EV / FCF
|
-76.9
x
|
-359
x
|
-48.1
x
|
42
x
|
-24.6
x
|
-44.8
x
|
-142
x
|
55.8
x
|
FCF Yield
|
-1.3%
|
-0.28%
|
-2.08%
|
2.38%
|
-4.07%
|
-2.23%
|
-0.7%
|
1.79%
|
Price to Book
|
1.97
x
|
3.69
x
|
4.86
x
|
3.2
x
|
1.8
x
|
1.38
x
|
1.28
x
|
1.18
x
|
Nbr of stocks (in thousands)
|
106,033
|
106,457
|
116,976
|
117,153
|
117,353
|
117,525
|
-
|
-
|
Reference price
2 |
73.04
|
147.5
|
233.8
|
216.9
|
144.5
|
116.9
|
116.9
|
116.9
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,589
|
3,129
|
3,328
|
7,320
|
9,617
|
6,028
|
7,373
|
8,733
|
EBITDA
1 |
1,037
|
818.7
|
871
|
3,476
|
3,370
|
1,252
|
1,903
|
2,237
|
EBIT
1 |
823.3
|
586.8
|
617
|
3,175
|
2,940
|
610.4
|
1,259
|
1,608
|
Operating Margin
|
22.94%
|
18.75%
|
18.54%
|
43.37%
|
30.57%
|
10.13%
|
17.08%
|
18.41%
|
Earnings before Tax (EBT)
1 |
563
|
373.5
|
133.6
|
2,433
|
246.7
|
830.7
|
1,493
|
2,711
|
Net income
1 |
533.2
|
375.8
|
123.7
|
2,690
|
1,573
|
768.3
|
1,536
|
2,932
|
Net margin
|
14.86%
|
12.01%
|
3.72%
|
36.75%
|
16.36%
|
12.75%
|
20.84%
|
33.57%
|
EPS
2 |
5.020
|
3.520
|
1.060
|
22.84
|
13.36
|
6.408
|
12.53
|
17.40
|
Free Cash Flow
1 |
-132.4
|
-51.56
|
-609.4
|
646.2
|
-824
|
-395
|
-122.1
|
331.8
|
FCF margin
|
-3.69%
|
-1.65%
|
-18.31%
|
8.83%
|
-8.57%
|
-6.55%
|
-1.66%
|
3.8%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
18.59%
|
-
|
-
|
-
|
14.83%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
24.02%
|
-
|
-
|
-
|
11.32%
|
Dividend per Share
2 |
1.470
|
1.540
|
1.560
|
1.580
|
-
|
1.644
|
1.662
|
1.723
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
830.6
|
894.2
|
1,128
|
1,480
|
2,092
|
2,621
|
2,580
|
2,370
|
2,311
|
2,356
|
1,363
|
1,399
|
1,588
|
1,830
|
1,487
|
EBITDA
1 |
217.6
|
228.7
|
431.9
|
610.2
|
1,190
|
1,244
|
1,596
|
1,032
|
453.3
|
289.1
|
187.8
|
249.9
|
344
|
429.7
|
414.4
|
EBIT
1 |
155.5
|
160.5
|
365.4
|
539.2
|
1,112
|
1,158
|
1,508
|
939.2
|
347.8
|
145
|
25.99
|
114.4
|
189.4
|
281.3
|
171
|
Operating Margin
|
18.72%
|
17.95%
|
32.4%
|
36.44%
|
53.17%
|
44.19%
|
58.46%
|
39.62%
|
15.05%
|
6.15%
|
1.91%
|
8.17%
|
11.93%
|
15.37%
|
11.5%
|
Earnings before Tax (EBT)
1 |
-516.8
|
-8.062
|
299.6
|
401.5
|
869.3
|
863.1
|
1,157
|
168.4
|
-158.2
|
-921
|
25
|
-
|
-
|
-
|
-
|
Net income
1 |
-392.8
|
-3.824
|
253.4
|
406.8
|
897.2
|
1,132
|
1,239
|
650
|
302.5
|
-617.7
|
107.9
|
116.3
|
171.2
|
196.2
|
362
|
Net margin
|
-47.29%
|
-0.43%
|
22.47%
|
27.49%
|
42.89%
|
43.21%
|
48%
|
27.43%
|
13.09%
|
-26.22%
|
7.91%
|
8.31%
|
10.78%
|
10.72%
|
24.35%
|
EPS
2 |
-3.360
|
-0.0300
|
2.150
|
3.460
|
7.610
|
9.600
|
10.51
|
5.520
|
2.570
|
-5.260
|
1.126
|
0.8800
|
1.310
|
1.763
|
3.080
|
Dividend per Share
2 |
0.3900
|
0.3900
|
0.3950
|
0.3950
|
0.3950
|
0.3950
|
0.4000
|
0.4000
|
0.4000
|
-
|
0.4120
|
0.4816
|
0.4850
|
0.4850
|
0.5942
|
Announcement Date
|
11/3/21
|
2/16/22
|
5/4/22
|
8/3/22
|
11/2/22
|
2/15/23
|
5/3/23
|
8/2/23
|
11/1/23
|
2/14/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
2,437
|
2,825
|
1,955
|
1,718
|
3,277
|
3,948
|
3,620
|
4,792
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.351
x
|
3.451
x
|
2.245
x
|
0.4943
x
|
0.9723
x
|
3.153
x
|
1.902
x
|
2.142
x
|
Free Cash Flow
1 |
-132
|
-51.6
|
-609
|
646
|
-824
|
-395
|
-122
|
332
|
ROE (net income / shareholders' equity)
|
17.1%
|
9.16%
|
8.31%
|
19%
|
30.1%
|
4.78%
|
12.6%
|
9.36%
|
ROA (Net income/ Total Assets)
|
7.37%
|
3.7%
|
4.39%
|
19.6%
|
15.5%
|
2.92%
|
6.8%
|
12.1%
|
Assets
1 |
7,237
|
10,156
|
2,817
|
13,745
|
10,128
|
26,334
|
22,610
|
24,178
|
Book Value Per Share
2 |
37.10
|
39.90
|
48.10
|
67.80
|
80.20
|
84.90
|
91.60
|
99.10
|
Cash Flow per Share
2 |
6.770
|
7.480
|
2.970
|
16.20
|
11.30
|
13.00
|
12.60
|
18.00
|
Capex
1 |
852
|
850
|
954
|
1,262
|
2,149
|
1,699
|
1,750
|
1,918
|
Capex / Sales
|
23.73%
|
27.18%
|
28.66%
|
17.24%
|
22.35%
|
28.18%
|
23.73%
|
21.96%
|
Announcement Date
|
2/19/20
|
2/17/21
|
2/16/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
116.9
USD Average target price
152.4
USD Spread / Average Target +30.39% Consensus |
1st Jan change
|
Capi.
|
---|
| -19.10% | 13.74B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | +35.12% | 12.81B |
Other Specialty Chemicals
|